Balkrishan Simba Gill
2018
In 2018, Balkrishan Simba Gill earned a total compensation of $4.5M as Chief Executive Officer at Evelo Biosciences, a 144% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $300,000 |
|---|---|
| Option Awards | $3,677,249 |
| Salary | $491,817 |
| Total | $4,469,066 |
Gill received $3.7M in option awards, accounting for 82% of the total pay in 2018.
Gill also received $300K in non-equity incentive plan and $491.8K in salary.
Rankings
In 2018, Balkrishan Simba Gill's compensation ranked 2,377th out of 14,244 executives tracked by ExecPay. In other words, Gill earned more than 83.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,377 out of 14,244 | 83rd |
Division Manufacturing | 872 out of 5,762 | 85th |
Major group Chemicals And Allied Products | 296 out of 2,125 | 86th |
Industry group Drugs | 240 out of 1,814 | 87th |
Industry Pharmaceutical Preparations | 185 out of 1,388 | 87th |
Source: SEC filing on April 25, 2019.
Gill's colleagues
We found two more compensation records of executives who worked with Balkrishan Simba Gill at Evelo Biosciences in 2018.
News
Evelo Biosciences Chief Development Officer Jonathan Zung receives $4.6M in 2021
April 26, 2022
Evelo Biosciences CEO Balkrishan Gill's 2020 pay falls 23% to $2.2M
April 26, 2021
Evelo Biosciences CEO Balkrishan Gill's 2019 pay falls 37% to $2.8M
April 27, 2020
Evelo Biosciences CEO Balkrishan Gill's 2018 pay jumps 144% to $4.5M
April 25, 2019